Bladder bacteria transplant shows promise for painful condition

This phase 1 trial tested a new treatment called urinary microbiota transplantation (UMT) for people with cystitis glandularis, a chronic bladder condition often linked to pelvic lipomatosis. The treatment involves placing processed donor urine bacteria into the bladder. After one month of weekly treatments, the UMT group reported fewer symptoms like frequent urination and pain, with a 58% response rate. The study suggests UMT works by reducing harmful metabolites and inflammation, not by killing bacteria.